[Product Release] GT895X Series Low-Voltage High-Speed Comparators
2025-06-26 10:47:13
Product
The GT895X series consists of low-power, high-speed comparators with internal hysteresis and a propagation delay of just 18ns. These devices are suitable for both 3V and 5V systems and consume only 160μA of quiescent current.
The GT895X series supports rail-to-rail input and output, with a common-mode input voltage range from -0.1V to (V+)+0.1V. The built-in hysteresis enhances noise immunity, even with slowly varying input signals, making the series well-suited for interfacing with CMOS and TTL logic circuits.
In terms of packaging:
GT8951 is available in SC70-5 and SOT23-5 packages.
GT8952 is available in MSOP8 and SOP8 packages.
GT8954 is available in TSSOP14 and SOP14 packages.
Features
Supply Voltage: 2.5V to 5.5V (±1.25V to ±2.75V)
Input Common-Mode Voltage Range: (V–) – 0.1V to (V+) + 0.1V
VOH: (V+) – 0.1V (Io = 4mA)
VOL: 100mV (Io = 4mA)
Propagation Delay (Low to High): 18ns
Propagation Delay (High to Low): 16ns
Rise Time: 10ns
Fall Time: 7.5ns
Quiescent Current per Comparator: 160μA
Input Offset Voltage: ±10mV
Hysteresis Voltage: 4.5mV
Common-Mode Rejection Ratio (CMRR): 75dB
Power Supply Rejection Ratio (PSRR): 70dB
Package Options: SOT23-5, SC70-5, SOP8, MSOP8, SOP14, TSSOP14
Advantages
High speed: propagation delay as low as 18ns, ideal for high-frequency signal comparison.
Low power: quiescent current only 160μA, suitable for battery-powered devices.
Rail-to-rail input/output: supports wide voltage range, compatible with CMOS/TTL logic.
Noise immunity: 4.5mV internal hysteresis reduces low-frequency noise and oscillation.
Application
The Application of Line Receiver
About Gtic
GTIC is a precision signal chain chip company focused on the design and sales of analog and high-precision signal chain products. Its diverse portfolio is widely used in industrial control, smart electric vehicles, test and measurement, renewable energy, smart manufacturing, intelligent buildings, environmental protection, and digital healthcare.
END